X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank90
3Y CAGR+6.0%
5Y CAGR+11.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+6.0%/yr
vs +18.5%/yr prior
5Y CAGR
+11.6%/yr
Recent deceleration
Acceleration
-12.5pp
Decelerating
Percentile
P90
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $72.72M | -10.9% |
| 2024 | $81.64M | +13.4% |
| 2023 | $72.02M | +17.9% |
| 2022 | $61.06M | +20.6% |
| 2021 | $50.65M | +20.8% |
| 2020 | $41.93M | +39.0% |
| 2019 | $30.16M | -2.6% |
| 2018 | $30.98M | +10.1% |
| 2017 | $28.13M | +57.7% |
| 2016 | $17.83M | - |